CRISPR-based POC Diagnostics Market, By Product Type (Diagnostic Kits, Reagents & Enzymes, Disposable Cartridges, and Assay Panels), By Technology Type, By Detection Method, By Application, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4698
|
Published Date
February 2026
|
Pages
367
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
CRISPR-based POC Diagnostics Market size was valued at US$ 505.12 Million in 2024, expanding at a CAGR of 15.85% from 2025 to 2032.
CRISPRbased pointofcare (POC) diagnostics are rapid molecular testing solutions that leverage CRISPR geneediting enzymes for highly specific and sensitive pathogen detection. The global CRISPRbased diagnostics market is projected to grow significantly from an estimated USD3.8billion in 2025 to potentially over USD7.5billion by 2030, reflecting strong demand for advanced rapid diagnostics in infectious disease management. Rising demand for decentralized, fast diagnostics—particularly for respiratory and emerging diseases—drives market growth, supported in part by public health initiatives that prioritize quick pathogen identification and outbreak control. Governments and health agencies worldwide increasingly emphasize rapid testing infrastructure to strengthen epidemic preparedness and reduce disease transmission.
Significant opportunities lie in developing multiplexed and instrumentfree assays with shorter turnaround times, which are essential for lowresource, remote, and community healthcare settings. A notable trend is the integration of CRISPRbased diagnostics with microfluidics and portable readers, enhancing both analytical accuracy and usability at the point of care. However, widespread adoption remains constrained by regulatory complexity, challenges in scaling manufacturing capacity, and limited longterm clinical validation required for routine diagnostics and largescale screening programs. Regulatory bodies have previously granted emergency use authorizations for CRISPR assays—such as SARSCoV2 tests during the COVID19 pandemic—demonstrating their potential utility under urgent public health conditions, though full standard approvals are still evolving.
CRISPR-based POC Diagnostics Market- Market Dynamics
Rising Adoption of Rapid and Decentralized Diagnostic Testing Across Healthcare Settings
The growing adoption of rapid, decentralized diagnostic testing across hospitals, clinics, and remote healthcare settings is a key driver of demand for CRISPR-based point-of-care (POC) diagnostics. These solutions are essential for enabling timely and accurate disease detection, particularly as healthcare systems increasingly prioritize early diagnosis, outbreak control, and personalized treatment strategies. CRISPR-based POC diagnostics allow rapid molecular detection of pathogens, genetic markers, and infectious agents directly at or near the patient site, eliminating reliance on centralized laboratories.
The rising reliance on fast-turnaround diagnostics in emergency care, infectious disease management, and public health surveillance is accelerating market adoption. Demand is particularly strong for portable, easy-to-use platforms suitable for primary care and low-resource settings, prompting manufacturers to develop compact, instrument-light CRISPR systems without compromising accuracy. Furthermore, the increasing frequency of infectious disease outbreaks has underscored the need for scalable, decentralized testing solutions, highlighting the value of POC diagnostics in reducing delays and enabling rapid intervention. The expanding use of POC testing for screening, surveillance, and home-based care further reinforces the importance of reliable, rapid, and user-friendly CRISPR-based diagnostic technologies.
CRISPR-based POC Diagnostics Market- Segmentation Analysis:
The Global CRISPR-based POC Diagnostics Market is segmented on the basis of Product Type, Technology Type, Detection Method, Application, and Region.
The market is segmented into four main product types: diagnostic kits, reagents & enzymes, disposable cartridges, and assay panels, with diagnostic kits clearly dominating the landscape. Diagnostic kits lead due to their direct clinical applicability, userfriendly formats, and suitability for pointofcare (POC) testing—an area that governments worldwide are actively promoting to expand access to timely diagnostics. In fact, multiple national health agencies have reported that over 60% of essential diagnostic testing in rural and underserved populations now relies on POC kits, reflecting policy priorities to strengthen decentralized healthcare delivery. Reagents and enzymes rank second, bolstered by continuous demand for assay development, customization, and repeated test usage; this is particularly true for CRISPRassociated enzymes, which are critical determinants of test sensitivity and specificity. With substantial government funding supporting advanced molecular diagnostics development—often exceeding hundreds of millions of dollars annually in major economies—reagents and enzymes remain vital components of both research and clinical testing workflows. Disposable cartridges follow as an increasingly important segment, driven by the global emphasis on singleuse, contaminationfree formats that simplify workflows and enhance scalability for mass screening and remote healthcare applications. Assay panels are gaining adoption due to rising demand for multiplex detection of multiple biomarkers in a single test; however, their broader uptake is currently tempered by higher development complexity and stringent regulatory requirements. Together, these product segments illustrate a clear industry shift toward integrated, scalable, and rapid diagnostic solutions that align with government priorities for broad, equitable access to advanced healthcare technologies.
When analyzed by technology type, the market is categorized into CRISPRCas12, CRISPRCas13, multiplex CRISPR systems, and CRISPRCas9 platforms. The CRISPRCas12 segment leads the market, driven by its superior analytical sensitivity, rapid reaction times, and strong suitability for decentralized diagnostics—capabilities highly valued in global public health strategies aimed at early disease detection and outbreak response. Public health authorities in multiple countries have highlighted the importance of sensitive, rapid diagnostics in pandemic preparedness plans, with CRISPRenabled platforms becoming integral to national testing initiatives. The CRISPRCas13 segment ranks second, propelled by its RNAtargeting capabilities, making it particularly effective for detecting RNA viruses and infectious diseases of high clinical relevance. As part of broader genomic surveillance programs, governments worldwide have expanded support for RNAbased diagnostic technologies, reflecting the critical role of such platforms in monitoring viral outbreaks and emerging pathogens. Multiplex CRISPR systems follow, gaining traction as demand increases for simultaneous detection of multiple pathogens or genetic targets in a single test. While these systems offer high throughput and comprehensive profiling, assay complexity and optimization challenges currently moderate their adoption relative to singletarget assays. CRISPRCas9 ranks next, as it remains more widely used in gene editing applications than in diagnostics and generally lacks inherent signal amplification features, which limits its suitability for rapid pointofcare deployment. Overall, technological prioritization in the market reflects a balance between performance characteristics, operational speed, and ease of integration into decentralized diagnostic platforms—key considerations emphasized in national health technology assessments and funding strategies aimed at strengthening diagnostics infrastructure globally.
CRISPR-based POC Diagnostics Market- Geographical Insights
The CRISPR-based point-of-care (POC) diagnostics market demonstrates notable regional differences in adoption and growth. North America currently leads the global market, supported by advanced healthcare infrastructure, substantial R&D investment, and a high concentration of biotechnology companies and academic research institutions. The United States, in particular, plays a pivotal role in accelerating the commercialization of CRISPR diagnostic platforms. Europe holds the second-largest share, driven by strong public health funding, collaborative research networks in countries such as Germany, the UK, and France, and increasing integration of CRISPR assays into clinical and laboratory workflows.
The Asia-Pacific region is expected to witness the fastest growth, fueled by rising healthcare expenditure, government initiatives promoting biotechnology innovation, and expanding adoption of rapid diagnostics across China, India, Japan, and Southeast Asia. Strategic collaborations highlight this regional momentum—for example, Indian biotech firm CrisprBits partnered with Molbio Diagnostics to develop and commercialize POC CRISPR tests, enhancing accessibility in both local and international markets.
CRISPR-based POC Diagnostics Market- Country Insights
Countrylevel dynamics in the CRISPRbased pointofcare (POC) diagnostics market reflect variations in healthcare priorities, investment environments, and innovation ecosystems. The United States leads globally, driven by substantial biotech R&D funding, supportive regulatory frameworks, and active commercialization of CRISPR diagnostic platforms, contributing to North America’s position as the largest regional share in the CRISPR diagnostics market. Globally, the CRISPRbased diagnostics market is projected to grow from an estimated USD3.5billion in 2025 to over USD17.0billion by 2035, highlighting strong ongoing investment and adoption trends. Europe follows closely, with countries such as Germany, the United Kingdom, and France supported by collaborative research networks, public health funding, and healthcare systems that increasingly incorporate rapid and accurate molecular diagnostics. Regulatory support and publicprivate research initiatives across the EU further encourage CRISPR assay integration into clinical workflows.
AsiaPacific markets, particularly China, India, and Japan, are experiencing rapid expansion due to rising infectious disease burdens, increased biotech investment, and growing healthcare infrastructure, positioning these nations for accelerated POC CRISPR adoption. Government initiatives and funding programs aimed at strengthening biotechnology research and improving diagnostic access are further supporting growth in these countries. Strategic industry developments also underscore regional momentum—for example, the acquisition of Sherlock Biosciences by OraSure Technologies in the U.S. broadened CRISPR diagnostic offerings, while Indian firms CrisprBits and Molbio Diagnostics entered a collaboration to codevelop and deploy POC CRISPR tests both domestically and internationally, reflecting broader government and industry focus on advancing rapid, decentralized diagnostic solutions.
CRISPR-based POC Diagnostics Market- Competitive Landscape:
The CRISPR-based point-of-care (POC) diagnostics market is highly dynamic, driven by rapid technological innovation, strategic partnerships, and consolidation among leading biotechnology and diagnostic firms. Key players, including Mammoth Biosciences, OraSure Technologies (via Sherlock Biosciences), Caspr Biotech, Integrated DNA Technologies (IDT), and GenScript, are actively developing and commercializing CRISPR-based diagnostic platforms that combine high sensitivity with ease of use in decentralized healthcare settings. Competitive advantages are established through superior assay performance, proprietary patent portfolios, and integration with portable diagnostic devices. Market activity also includes strategic acquisitions aimed at enhancing technological capabilities and accelerating time-to-market; for example, Sherlock Biosciences acquired Sense Bio Detection to integrate instrument-free molecular testing hardware with its CRISPR technology, expanding its POC diagnostic portfolio.
Collaborations further strengthen market positions, exemplified by the partnership between CrisprBits and Molbio Diagnostics, which focuses on co-developing and distributing rapid CRISPR-based POC tests. This alliance leverages CrisprBits’ PathCrisp platform alongside Molbio’s manufacturing and distribution capabilities to deliver fast, affordable, and accessible diagnostics across global healthcare settings.
Recent Developments:
- In August 2023, CrisprBits and Molbio Diagnostics formally launched their strategic collaboration to jointly develop and commercialize CRISPR-based POC tests, enhancing accessibility and accelerating adoption in diverse clinical and decentralized environments.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Agilent Technologies
- AstraZeneca
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Caspr Biotech
- Danaher Corporation
- Detect Inc.
- Hologic
- Illumina
- Lucira Health
- Mammoth Biosciences
- Merck KGaA
- Qiagen
- QuidelOrtho
- Roche Diagnostics
- Sherlock Biosciences
- Siemens Healthineers
- Thermo Fisher Scientific
- Twist Bioscience
- Others
GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Diagnostic Kits
- Reagents & Enzymes
- Disposable Cartridges
- Assay Panels
GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY TECHNOLOGY TYPE- MARKET ANALYSIS, 2019 - 2032
- CRISPR-Cas9
- CRISPR-Cas12
- CRISPR-Cas13
- Multiplex CRISPR Systems
GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY DETECTION METHOD- MARKET ANALYSIS, 2019 - 2032
- Fluorescence-Based Detection
- Colorimetric Detection
- Electrochemical Detection
- Lateral Flow Readout
GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Infectious Disease Detection
- Genetic Disorder Screening
- Oncology Diagnostics
- Antimicrobial Resistance Testing
GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. CRISPR-based POC Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. CRISPR-based POC Diagnostics Market Snippet by Product Type
2.1.2. CRISPR-based POC Diagnostics Market Snippet by Technology Type
2.1.3. CRISPR-based POC Diagnostics Market Snippet by Detection Method
2.1.4. CRISPR-based POC Diagnostics Market Snippet by Application
2.1.5. CRISPR-based POC Diagnostics Market Snippet by Country
2.1.6. CRISPR-based POC Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. CRISPR-based POC Diagnostics Key Market Trends
3.1. CRISPR-based POC Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. CRISPR-based POC Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. CRISPR-based POC Diagnostics Market Opportunities
3.4. CRISPR-based POC Diagnostics Market Future Trends
4. CRISPR-based POC Diagnostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. CRISPR-based POC Diagnostics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. CRISPR-based POC Diagnostics Market Landscape
6.1. CRISPR-based POC Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. CRISPR-based POC Diagnostics Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Diagnostic Kits
7.1.3. Reagents & Enzymes
7.1.4. Disposable Cartridges
7.1.5. Assay Panels
8. CRISPR-based POC Diagnostics Market – By Technology Type
8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2024 & 2032 (%)
8.1.2. CRISPR-Cas9
8.1.3. CRISPR-Cas12
8.1.4. CRISPR-Cas13
8.1.5. Multiplex CRISPR Systems
9. CRISPR-based POC Diagnostics Market – By Detection Method
9.1. Overview
9.1.1. Segment Share Analysis, By Detection Method, 2024 & 2032 (%)
9.1.2. Fluorescence-Based Detection
9.1.3. Colorimetric Detection
9.1.4. Electrochemical Detection
9.1.5. Lateral Flow Readout
10. CRISPR-based POC Diagnostics Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
10.1.2. Infectious Disease Detection
10.1.3. Genetic Disorder Screening
10.1.4. Oncology Diagnostics
10.1.5. Antimicrobial Resistance Testing
11. CRISPR-based POC Diagnostics Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. CRISPR-based POC Diagnostics Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. CRISPR-based POC Diagnostics Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. CRISPR-based POC Diagnostics Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. CRISPR-based POC Diagnostics Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. CRISPR-based POC Diagnostics Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- CRISPR-based POC Diagnostics Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Abbott Laboratories
12.2.2. Agilent Technologies
12.2.3. AstraZeneca
12.2.4. Becton, Dickinson and Company
12.2.5. Bio-Rad Laboratories
12.2.6. Caspr Biotech
12.2.7. Danaher Corporation
12.2.8. Detect Inc.
12.2.9. Hologic
12.2.10. Illumina
12.2.11. Lucira Health
12.2.12. Mammoth Biosciences
12.2.13. Merck KGaA
12.2.14. Qiagen
12.2.15. QuidelOrtho
12.2.16. Roche Diagnostics
12.2.17. Sherlock Biosciences
12.2.18. Siemens Healthineers
12.2.19. Thermo Fisher Scientific
12.2.20. Twist Bioscience
12.2.21. Others
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Agilent Technologies
- AstraZeneca
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Caspr Biotech
- Danaher Corporation
- Detect Inc.
- Hologic
- Illumina
- Lucira Health
- Mammoth Biosciences
- Merck KGaA
- Qiagen
- QuidelOrtho
- Roche Diagnostics
- Sherlock Biosciences
- Siemens Healthineers
- Thermo Fisher Scientific
- Twist Bioscience
- Others
GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Diagnostic Kits
- Reagents & Enzymes
- Disposable Cartridges
- Assay Panels
GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY TECHNOLOGY TYPE- MARKET ANALYSIS, 2019 - 2032
- CRISPR-Cas9
- CRISPR-Cas12
- CRISPR-Cas13
- Multiplex CRISPR Systems
GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY DETECTION METHOD- MARKET ANALYSIS, 2019 - 2032
- Fluorescence-Based Detection
- Colorimetric Detection
- Electrochemical Detection
- Lateral Flow Readout
GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Infectious Disease Detection
- Genetic Disorder Screening
- Oncology Diagnostics
- Antimicrobial Resistance Testing
GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
